Exposure to golimumab

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	3

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03394586 (ClinicalTrials.gov)	January 1, 2018	28/12/2017	Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab	Real-world Data Regarding Treatment of Ulcerative Colitis Patients With Golimumab	Ulcerative Colitis;Flare Up, Symptom	Drug: Exposure to golimumab	University of Zurich	NULL	Unknown status	N/A	N/A	All	100		Switzerland
2	NCT05405465 (ClinicalTrials.gov)	January 1, 2018	31/5/2022	Effectiveness of Golimumabin Patients With Ulcerative Colitis: Results of a Real-life Study in Switz ...	Effectiveness of Golimumabin Patients With Ulcerative Colitis: Results of a Real-life Study in Switz ...	Ulcerative Colitis;Flare Up, Symptom	Drug: Exposure to golimumab	University of Zurich	Merck Sharp & Dohme LLC	Completed	N/A	N/A	All	103		Switzerland
3	EUCTR2017-001374-42-GB (EUCTR)	21/07/2017	19/07/2017	Measuring levels of golimumab toimprove the understanding of differences in its effectiveness amongs ...	Study of the Golimumab Exposure-Response Relationship using Serum Trough Levels - GO-LEVEL	Ulcerative Colitis (UC);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Simponi Product Name: Golimumab	Guy's and St Thomas' NHS Foundation Trust	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	112	Phase 4	United Kingdom

First Previous1Next Last